TheProfitWatch

AVIR - Atea Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.0 -0.02 (-0.83%) 0.0 (0.0%) 0.0 (0.0%) -0.01 (-0.34%) 0.0 (0.0%) -0.02 (-0.83%) 0.0 (0.0%) -0.04 (-1.32%)

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.44
Diluted EPS:
-0.44
Basic P/E:
-6.7614
Diluted P/E:
-6.7614
RSI(14) 1m:
100.0
VWAP:
2.98
RVol:

Events

Period Kind Movement Occurred At

Related News